Found: 139
Select item for more details and to access through your institution.
Impact of the COVID-19 Pandemic on Prostate Cancer Diagnosis, Staging, and Treatment: A Population-Based Study in Northern Italy.
- Published in:
- Biology (2079-7737), 2024, v. 13, n. 7, p. 499, doi. 10.3390/biology13070499
- By:
- Publication type:
- Article
Characteristics and Outcomes of Colorectal Cancer Patients Cared for by the Multidisciplinary Team in the Reggio Emilia Province, Italy.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2390, doi. 10.3390/cancers16132390
- By:
- Publication type:
- Article
HELLS regulates transcription in T-cell lymphomas by reducing unscheduled R-loops and by facilitating RNAPII progression.
- Published in:
- Nucleic Acids Research, 2024, v. 52, n. 11, p. 6171, doi. 10.1093/nar/gkae239
- By:
- Publication type:
- Article
Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 12, p. 6447, doi. 10.3390/ijms25126447
- By:
- Publication type:
- Article
Outcomes before and after Implementation of the ERAS (Enhanced Recovery after Surgery) Protocol in Open and Laparoscopic Colorectal Surgery: A Comparative Real-World Study from Northern Italy.
- Published in:
- Current Oncology, 2024, v. 31, n. 6, p. 2907, doi. 10.3390/curroncol31060222
- By:
- Publication type:
- Article
Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 6, p. 860, doi. 10.1111/ejh.14181
- By:
- Publication type:
- Article
Teclistamab‐cqyv in multiple myeloma.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 320, doi. 10.1111/ejh.14121
- By:
- Publication type:
- Article
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05013-0
- By:
- Publication type:
- Article
Tagraxofusp in myeloid malignancies.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3234
- By:
- Publication type:
- Article
Incidence and Survival of Testicular Cancers in a Province in Northern Italy and Their Association with Second Tumors.
- Published in:
- Biology (2079-7737), 2023, v. 12, n. 11, p. 1409, doi. 10.3390/biology12111409
- By:
- Publication type:
- Article
Myelodysplastic syndromes with ring sideroblasts.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 612, doi. 10.1002/hon.3125
- By:
- Publication type:
- Article
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 19, p. 14558, doi. 10.3390/ijms241914558
- By:
- Publication type:
- Article
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 18, p. 2226, doi. 10.3390/cells12182226
- By:
- Publication type:
- Article
Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1198992
- By:
- Publication type:
- Article
Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic Purpura.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
SARS-CoV-2 Infection, Vaccination and Risk of Death in People with An Oncological Disease in Northeast Italy.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 9, p. 1333, doi. 10.3390/jpm13091333
- By:
- Publication type:
- Article
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00434-x
- By:
- Publication type:
- Article
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1182971
- By:
- Publication type:
- Article
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 6, p. 1409, doi. 10.1007/s00277-023-05217-2
- By:
- Publication type:
- Article
Iron chelation therapy.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 5, p. 490, doi. 10.1111/ejh.13935
- By:
- Publication type:
- Article
Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2199, doi. 10.3390/cancers15082199
- By:
- Publication type:
- Article
The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1063636
- By:
- Publication type:
- Article
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD + -Lowering Agents.
- Published in:
- Antioxidants, 2023, v. 12, n. 2, p. 494, doi. 10.3390/antiox12020494
- By:
- Publication type:
- Article
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15691, doi. 10.3390/ijms232415691
- By:
- Publication type:
- Article
A High Percentage of CD16+ Monocytes Correlates with the Extent of Bone Erosion in Chronic Lymphocytic Leukemia Patients: The Impact of Leukemic B Cells in Monocyte Differentiation and Osteoclast Maturation.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5979, doi. 10.3390/cancers14235979
- By:
- Publication type:
- Article
The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 962, doi. 10.1002/hon.3063
- By:
- Publication type:
- Article
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia.
- Published in:
- Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00305-x
- By:
- Publication type:
- Article
Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.894419
- By:
- Publication type:
- Article
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity.
- Published in:
- Biomedicines, 2022, v. 10, n. 3, p. 520, doi. 10.3390/biomedicines10030520
- By:
- Publication type:
- Article
LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 1, p. 40, doi. 10.1002/hon.2938
- By:
- Publication type:
- Article
Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5518, doi. 10.3390/cancers13215518
- By:
- Publication type:
- Article
Oleil Hydroxytyrosol (HTOL) Exerts Anti-Myeloma Activity by Antagonizing Key Survival Pathways in Malignant Plasma Cells.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 21, p. 11639, doi. 10.3390/ijms222111639
- By:
- Publication type:
- Article
OAB-009: Genome-wide CRISPR interference screen identifies RNA Regulator of Lipogenesis (RROL) as a leading LncRNA dependency in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S6, doi. 10.1016/S2152-2650(21)02083-8
- By:
- Publication type:
- Article
Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax Sensitivity.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4898, doi. 10.3390/cancers13194898
- By:
- Publication type:
- Article
ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape †.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 19, p. 10814, doi. 10.3390/ijms221910814
- By:
- Publication type:
- Article
miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4365, doi. 10.3390/cancers13174365
- By:
- Publication type:
- Article
Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3213, doi. 10.3390/cancers13133213
- By:
- Publication type:
- Article
Genomics of Smoldering Multiple Myeloma: Time for Clinical Translation of Findings?
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3319, doi. 10.3390/cancers13133319
- By:
- Publication type:
- Article
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma.
- Published in:
- Drug Design, Development & Therapy, 2021, v. 15, p. 2969, doi. 10.2147/DDDT.S295215
- By:
- Publication type:
- Article
Validation of the Alternative International Prognostic Score‐E (AIPS‐E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O‐CLL1‐GISL protocol.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 6, p. 831, doi. 10.1111/ejh.13614
- By:
- Publication type:
- Article
Genomic Instability in Multiple Myeloma: A "Non-Coding RNA" Perspective.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2127, doi. 10.3390/cancers13092127
- By:
- Publication type:
- Article
The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1235, doi. 10.3390/cancers13061235
- By:
- Publication type:
- Article
Epigenetic Regulation of Mitochondrial Quality Control Genes in Multiple Myeloma: A Sequenom MassARRAY Pilot Investigation on HMCLs.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 6, p. 1295, doi. 10.3390/jcm10061295
- By:
- Publication type:
- Article
What Is New in the Treatment of Smoldering Multiple Myeloma?
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 3, p. 421, doi. 10.3390/jcm10030421
- By:
- Publication type:
- Article
Antitumor Effects of PRIMA-1 and PRIMA-1 Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 1, p. 98, doi. 10.3390/cells10010098
- By:
- Publication type:
- Article
Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.593383
- By:
- Publication type:
- Article
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75364-3
- By:
- Publication type:
- Article
Jagged Ligands Enhance the Pro-Angiogenic Activity of Multiple Myeloma Cells.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2600, doi. 10.3390/cancers12092600
- By:
- Publication type:
- Article
Non-Coding RNAs in Multiple Myeloma Bone Disease Pathophysiology.
- Published in:
- Non-Coding RNA, 2020, v. 6, n. 3, p. 1, doi. 10.3390/ncrna6030037
- By:
- Publication type:
- Article
LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems?
- Published in:
- Non-Coding RNA, 2020, v. 6, n. 3, p. 1, doi. 10.3390/ncrna6030026
- By:
- Publication type:
- Article